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Abstract
Pseudomonas aeruginosa (PA) is an opportunistic pathogen that causes diverse human
infections including chronic airway infection in patients with cystic fibrosis (CF). Comparing
the genomes of CF and non-CF PA isolates has great potential to identify the genetic basis
of pathogenicity. To gain a deeper understanding of PA adaptation in CF airways, we per-
formed a genome-wide association study (GWAS) on 1,001 PA genomes. Genetic varia-
tions identified among CF isolates were categorized into (i) alterations in protein-coding
regions, either large- or small-scale, and (ii) polymorphic variation in intergenic regions. We
introduced each CF-associated genetic alteration into the genome of PAO1, a prototype PA
strain, and validated the outcomes experimentally. Loci readily mutated among CF isolates
included genes encoding a probable sulfatase, a probable TonB-dependent receptor
(PA2332~PA2336), L-cystine transporter (YecS, PA0313), and a probable transcriptional
regulator (PA5438). A promoter region of a heme/hemoglobin uptake outer membrane
receptor (PhuR, PA4710) was also different between the CF and non-CF isolate groups.
Our analysis highlights ways in which the PA genome evolves to survive and persist within
the context of chronic CF infection.
Author summary
Understanding how human pathogens, such as Pseudomonas aeruginosa (PA), adapt to
the host environment during prolonged infections can provide important information for
the treatment of disease. In this study, we compared the genome sequences of PA isolates
from cystic fibrosis (CF) and non-CF patients and identified genetic variation that was
significantly associated with CF disease. CF-associated genetic variations included: (i)
the deletion of three amino acids in a transcriptional regulator (PA5438), which leads to
decreased antibiotic susceptibility, enhanced virulence expression and sustained biofilm
production in the presence of transferrin, and (ii) the insertion of three amino acids in a
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cystine transporter (PA0313), which results in decreased pyochelin production. Further-
more, single nucleotide replacement in a promoter was identified and shown to upregulate
the cellular process for iron acquisition. Our bioinformatics analyses, linked with experi-
mental validation via genetic manipulation and phenotypic investigation of mutants, pro-
vides novel insights into the genomic plasticity of PA during chronic CF infection.
Introduction
Pseudomonas aeruginosa (PA) is an ubiquitous gram-negative bacterium that can cause disease
in plants and animals [1]. PA infection can cause acute syndromes such as pneumonia and
bloodstream infections, as well as chronic airway infections in patients with cystic fibrosis (CF).
CF is a well-known genetic disorder caused by a mutated cystic fibrosis transmembrane conduc-
tance regulator (CFTR) protein. CFTR disruption alters the condition of the lung such that the
increasingly dehydrated viscous mucus layer provides a favorable habitat for several pathogens,
such as PA, which can infect opportunistically and persist over an extended period of time [2].
The ecological versatility of PA is thought to be associated with its relatively large genome
containing numerous regulatory genes that confer an advantage in adapting during prolonged
infections [3]. Within-host mutation of PA isolates from a single CF patient have been ana-
lyzed to better understand the underlying genetics of adaptation [4]. Expression studies have
also been performed on PA grown in CF sputum and have identified altered expression of
genes encoding amino acid biosynthesis and degradation, and quinolone signaling [5,6].
The lasR gene, which encodes an important quorum-sensing regulator, has frequently been
detected among isolates from CF patients [7,8], however, the significance of this mutation is
unclear. Mutations leading to increased antibiotic tolerance have also been identified in PA
inhabiting the CF airway [9–11]. Furthermore, PA clonal lineages vary across different CF
patients, depending on the sputum composition [12–15], and even within an individual
patient over time [16,17]. Together, these findings suggest that PA is an adaptable organism
that responds flexibly to changing environments.
Most large-scale genetic studies have focused principally on CF isolates. Therefore, in
the absence of a comparator non-CF PA population, it is difficult to identify specific genetic
variations that are associated with the CF environment. In this study, we compared 1,001 PA
genomes sampled from both CF and non-CF clinical isolates. Genome-wide association stud-
ies (GWASs) have been useful in uncovering causal relationships between genetic variations
and disease phenotypes in human populations [18], with over 4,000 human GWAS conducted
to date [19]. In contrast to human genomes, bacterial genomes of the same species can vary in
size, gene repertoire, and gene arrangement [20]. Because of this genomic variability, addi-
tional considerations must be made when performing bacterial GWAS [21–25]. In this study,
we selected the genomes of PA isolates of known origin and performed a GWAS based on k-
mer counting [22,23,26], a modified method that permits association mapping of genes and
intergenic regions of the PAO1 reference genome. Results provided here expand our current
understanding of how gene-level changes correlate with mechanisms of PA adaptation to the
CF lung environment.
Results and discussion
P. aeruginosa population structure
Most studies aimed at better understanding chronic PA infection in CF patients have focused
only on CF isolates [14,16]. It is therefore unclear whether genetic variations highlighted in
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these studies are important in the context of adaptation to the CF lung. Here, we assembled a
collection of 2,167 PA genomes from the Pseudomonas Genome Database [27], including
genomes from both CF and non-CF individuals. Genomes of unknown origin were removed
and a phylogeny was constructed using 1,001 genomes of known origin (Fig 1A). In order to
remove clonal isolates that may increase any potential confounding lineage effects in the subse-
quent GWAS, the dataset was trimmed to 636 genomes (S1 Fig, S1 Data), maintaining 99.8%
diversity of original selection and the overall structure of the phylogenetic tree. Isolates from
CF patients could be identified from all parts of the phylogeny, including the previously
described groups A and B; and the long branching groups C1 and C2 [28]. Most CF isolates
(409 among 422) belonged to group A.
Fig 1. Visualization of significantly different regions and proteins with large-scale mutation. (A) Phylogenetic tree was constructed with 1,001
genomes with known host disease information. Black and red leaves each indicate non-CF and CF isolates, and the numbers of CF and non-CF
genomes for constructing the phylogenetic tree are placed inside brackets. Most of the CF isolates are located in group A, which includes the majority of
genomes, and the smaller groups are designated group B, C1 and C2. (B) 31-mers that were significantly associated with CF and non-CF groups were
aligned to the whole PAO1 genome and visualized by Phandango. Regions marked by asterisks are ribosomal DNA sequences and ‘hs’ marks the
hotspot region where a large number of candidate 31-mers align. The higher the point representing a 31-mer, the more significant the lrt p-value. (C)
Proteins with large-scale mutation from the PAO1 genome and Lrt p-values calculated for clustering performed under two conditions (S95L95: 95%
similarity and 95% length coverage; S70L95: 70% similarity and 95% length coverage) are described in the first and second columns as per the color
index beneath the heatmap. ‘hs’ indicates candidate proteins located within the hotspot region in (B).
https://doi.org/10.1371/journal.ppat.1009681.g001
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Identification of CF-associated genetic elements
In total, 636 genomes were used to perform a GWAS using Pyseer [29]. These comprised
206 genomes from CF and 430 from non-CF. A k-mer based approach was implemented to
include variability within intergenic regions. We selected k-mers with a length of 31 base pairs
(31-mer) consistent with other studies that have adopted similar approaches and tested the
effect of changes in k-mer length on GWAS sensitivity and false positive associations [22,23].
Significantly associated k-mers (p-value cutoff = 2.8e-08) were aligned to the PAO1 reference
genome and visualized using Phandango [30] (Fig 1B).
GWAS analysis identified 41,685 k-mers associated with CF with a p-value < 2.8e-08. Of
these, 489 de-novo assembled contigs mapped to 109 protein-coding genes, six untranslated
regions and 29 intergenic regions in the PAO1 reference genome. Four most meaningful
peaks marked with asterisks in Fig 1B are rDNA sequences. A greater number of CF isolates
did not seem to have 16S and 23S rDNA sequences compared with the non-CF group. How-
ever, we verified that several of these CF isolates (AU2342, AU6462, AU9739, AU10409,
AU16821 and AU25116) do have 16S rDNA by PCR-amplifying and sequencing the 16S
rDNA regions. By extension, we believe that the lack of detection of 16S and 23S rDNA
sequences from several CF isolates have arisen from an in silico error. Despite this, the number
of genes annotated using Prokka [31] were not significantly different between genomes and
they were therefore included in the input database.
GWAS elements associated with allelic variation in P. aeruginosa from CF
patients
Focusing on the k-mers that were mapped to the PAO1 reference genome, we obtained amino
acid sequences for each gene from all isolate genomes. Two different homology clustering
thresholds were used: 95% similarity and 95% gene length coverage (S95L95) and 70% similar-
ity and 95% gene length coverage (S70L95) (S2 and S3 Data). GWAS results were then filtered
by allele frequency using the likelihood-ratio test (lrt) p-values in Pyseer for both conditions
(Fig 1C). This provided a list of candidate genes with multiple associated alleles. We hereinaf-
ter refer to these genes with multiple co-localized mutations to contain large-scale mutations.
Variation in MucA (PA0763) served as a positive control, as MucA mutation is frequently
observed in CF isolates [32,33].
Large-scale alterations in protein-coding regions
Most candidate associated genes were identified within the prominent hs region (Fig 1C), with
the most significant lrt p-value (p-value = 2.02e-22) associated with a probable TonB-depen-
dent receptor (S2 Data). Differences in the strength of association were noted across amino
acid residues for PA2335 (Fig 2A). Analysis of raw filter p-values seemed to suggest an oppos-
ing conclusion in relation to the importance of PA2335 alteration in PA adaptation to the CF
airway. However, these raw p-values are not weighted to account for the population structure
(Fig 2B and 2C). Mapping variations in PA2335 against the phylogeny demonstrated align-
ment of the CF phenotype with the presence of its homolog, except for region a (Fig 2C). This
region corresponds to the group B isolates (S1 Fig) and suggests that these isolates possess
alternative CF associations. This pattern was also seen for variants in the PA2333, PA2334, and
PA2336 genes. Variation in PA2332 was associated with the CF phenotype across the entire
population suggesting it may have a broad influence in CF adaptation (S2 Data). This is consis-
tent with a previous study that identified lineage-specific markers for groups A and B, includ-
ing genes PA2333~PA2336 which were over-represented in group A [28].
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Functional annotation of proteins with large-scale mutations was performed using Blas-
tKOALA [34]. KEGG ontology (KO) [35], definition, and pathway information of the candi-
date associated genes were identified in the CF or non-CF isolates (Table 1, S3 Data). Almost
all of the large-scale mutations were more significantly associated with PA from CF patients.
Large scale mutations of MucA (PA0763) are well known in CF isolates to result in increased
alginate production and thus contribute to the mucoid phenotype, promoting infection
[32,33,36,37]. PA2020 is a negative regulator of the MexXY efflux pump, which expels antibiot-
ics from the cell [38]. Increased MexXY expression level and antibiotic resistance are induced
by disruption to the PA2020 regulator. Moreover, CF sputum contains mucins, free amino
acids, lactate, and glucose as a potential energy source and PA preferentially uses organic and
amino acids over glucose as an energy source [39]. For this reason, we speculate that some CF
Fig 2. PA2335 candidate with the lowest lrt p-value in the large-scale mutation group. (A) Total amino acid residues of PA2335 are presented and
each amino acid locus is represented by individual squares. The color of each square indicates the lrt p-value assigned to that amino acid residue based
on Pyseer results and colors are assigned according to the index above the heatmap, which was generated based on the negative logs of the maximum
and minimum lrt p-values from the Pyseer result of amino acid locus. ‘N’ and ‘C’ mark the N- and C-terminus of PA2335, respectively. (B) Pyseer result
of the PA2335 cluster is shown. Different conditions used in clustering and the frequency of the PA2335 large alteration are described in ‘condition’ and
‘af’ columns. Population structure is not considered in the calculation of filter p-values, but it is for the calculation of lrt p-values. (C) The phylogenetic
tree of 636 genomes and their associated disease status are shown. Red and black lines in the ‘id’ row indicate genomes isolated from CF and non-CF
patients, respectively. Black lines in the second and third rows indicate that the homolog of PA2335 clustered with the PAO1 protein at given clustering
thresholds (S95L95:S70L95). Red lines indicate that the homolog did not cluster with the PAO1 protein. Genomes in region a are included in group B
indicated in S1 Fig.
https://doi.org/10.1371/journal.ppat.1009681.g002
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isolates have evolved with mutations in glucose catabolism genes (PA2321 and PA3193) to
avoid spending unnecessary energy in catabolizing a less optimal carbon source (glucose).
Additionally, mannitol has been used as a therapeutic treatment to increase mucociliary clear-
ance in the airway and simultaneously induce tobramycin sensitivity in PA by generating a
proton motive force [40]. Therefore, we postulate that exposure through the concurrent thera-
peutic use of mannitol and antibiotics in CF patients may be the background from which the
mutations arose in the gene cassette (PA2338, PA2340, PA2341, and PA2342). These large-
scale mutations are highlighted in bold in Table 1.
Small-scale alterations in protein-coding regions
Large-scale mutations are more likely to cause loss-of-function than scattered substitutions
in homologous sequence (small-scale mutation). However, adaptation to the CF lung may
Table 1. KEGG annotation of candidate proteins with large-scale mutation. All large-scale mutations were annotated by Blastkoala. Proteins with KEGG information are
listed in the ‘Query’ column, and KEGG ontology (KO), definition, and related pathway information are shown. Proteins discussed in the results are highlighted in bold.
Query KO Definition Pathway
PA0763 K03597 sigma-E factor negative regulatory protein RseA
PA1091 K20444 O-antigen biosynthesis protein
PA2020 K18129 TetR/AcrR family transcriptional regulator, mexXY operon repressor Beta-Lactam resistance
PA2320 K06145 LacI family transcriptional regulator, gluconate utilization system Gnt-I transcriptional
repressor
PA2321 K00851 gluconokinase Pentose phosphate pathway
PA2322 K03299 gluconate:H+ symporter, GntP family
PA2323 K00131 glyceraldehyde-3-phosphate dehydrogenase (NADP+) Glycolysis / Gluconeogenesis, Pentose phosphate
pathway
PA2327 K02050 NitT/TauT family transport system permease protein
PA2328 K02051 NitT/TauT family transport system substrate-binding protein
PA2329 K02049 NitT/TauT family transport system ATP-binding protein
PA2335 K02014 iron complex outer membrane recepter protein
PA2338 K10227 sorbitol/mannitol transport system substrate-binding protein ABC transporters
PA2340 K10229 sorbitol/mannitol transport system permease protein ABC transporters
PA2341 K10111 multiple sugar transport system ATP-binding protein ABC transporters
PA2342 K00045 mannitol 2-dehydrogenase Fructose and mannose metabolism
PA2343 K00854 xylulokinase
PA2344 K00847 fructokinase Fructose and mannose metabolism
PA2345 K17218 sulfide:quinone oxidoreductase Sulfur metabolism
PA2348 K20938 long-chain alkane monooxygenase
PA2349 K02073 D-methionine transport system substrate-binding protein ABC transporters
PA2350 K02071 D-methionine transport system ATP-binding protein ABC transporters
PA2351 K02072 D-methionine transport system permease protein ABC transporters
PA2352 K01126 glycerophosphoryl diester phosphodiesterase Glycerophospholipid metabolism
PA3193 K00845 glucokinase Glycolysis / Gluconeogenesis
PA3540 K00066 GDP-mannose 6-dehydrogenase Fructose and mannose metabolism
PA3617 K03553 recombination protein RecA Homologous recombination
PA3687 K01595 phosphoenolpyruvate carboxylase Pyruvate metabolism
PA4216 K20262 dihydrophenazinedicarboxylate synthase Phenazine biosynthesis, Quorum sensing
PA4701 K07028 uncharacterized protein
PA4963 K09857 uncharacterized protein
PA5025 K01740 O-acetylhomoserine (thiol)-lyase Cysteine and methionine metabolism
https://doi.org/10.1371/journal.ppat.1009681.t001
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also involve substitutions that alter protein-coding regions leading to additive effects. To inves-
tigate this, we analyzed the top 10 amino acid residues of the small-scale mutations (Tables 2
and 3). For the genes containing the most significant CF-associated variation, the functional
genomics was further analyzed with laboratory validation experiments.
Mutations in a putative transcriptional regulator (PA5438)
Identification and experimental validation. Mutations at amino acid loci 272–274 (SLR)
in a probable transcriptional regulator gene (PA5438) were strongly associated with CF isolates
(Table 2 and Fig 3A). The amino acid sequence ‘SLR’ was deleted in the 2,419th gene of the CF
isolate 18A_661, a PA5438 homolog (Fig 3B). The SLR deletion in the PA5438 protein exhibits
a highly positive correlation with CF isolates overall (Fig 3C), and the PA5438 sequences
(except for the SLR sequence region) were exactly identical to the reference PA5438 sequence.
Domain search with SUPERFAMILY 2 [41] predicted these amino acids to be a part of a sugar
isomerase (SIS) domain (Fig 3D). Therefore, we constructed an in-frame deletion mutant,
Table 2. Top 10 amino acid residues of the small-scale mutation group with 31-mers aligned to the PAO1 genome. Top 10 amino acid residues according to Pyseer
results with 31-mers aligned to the PAO1 genome are presented. The reference protein corresponding to each residue is presented in the ‘protein’ column, and the ‘locus’
column contains the locus of the mutation and amino acid residue of the reference protein where the mutation is detected. SLR sequences of PA5438 are highlighted in
bold. Multiple types of mutation at each locus of the reference protein may be present and detailed information is provided in S3 Data.
protein locus af filter-pvalue lrt-pvalue description
PA5438 272S 0.075 7.03E-20 9.92E-17 Probable transcriptional regulator
PA5438 273L 0.079 1.20E-19 4.41E-15 Probable transcriptional regulator
PA5438 274R 0.08 6.33E-19 3.36E-14 Probable transcriptional regulator
PA4914 73A 0.05 2.71E-14 7.30E-13 Transcriptional regulator, AmaR
PA3355 384D 0.05 2.71E-14 3.48E-12 Hypothetical protein
PA2354 362G 0.09 3.36E-13 2.27E-11 SfnR1
PA2354 369E 0.08 2.20E-14 3.33E-11 SfnR1
PA2354 370R 0.08 2.20E-14 3.33E-11 SfnR1
PA2354 371A 0.08 2.20E-14 3.33E-11 SfnR1
PA2354 373R 0.08 2.20E-14 3.33E-11 SfnR1
https://doi.org/10.1371/journal.ppat.1009681.t002
Table 3. Top 10 amino acid residues of the small-scale mutation group whose 31-mers did not align to the PAO1 genome. Top 10 amino acid residues according to
Pyseer results whose 31-mers did not align to the PAO1 genome are shown. Reference proteins from genomes other than PAO1 and the PAO1 homolog of this reference
protein are presented in columns ‘protein’ and ‘homolog’. The ‘locus’ indicates the mutation and amino acid of the reference protein where the mutation is detected. Multi-
ple types of mutation at each locus of the reference protein may be present and detailed information is provided in S3 Data. The reference protein name in the “protein”
column is composed of the genome id, connected by the latter underscore sign, to gene number within that genome. All sequences of the reference proteins in Table 3 are
provided in S4 Data.
Protein locus af filter-pvalue lrt-pvalue homolog (PAO1) description
AU17965_3981_04951 162S 0.0708 1.27E-19 3.80E-16 PA0313 L-cystine transporter of ABC system YecS
AU17965_3981_04951 163L 0.0708 1.27E-19 3.80E-16 PA0313 L-cystine transporter of ABC system YecS
AU17965_3981_04951 164I 0.0708 1.27E-19 3.80E-16 PA0313 L-cystine transporter of ABC system YecS
105738_3985_01941 57G 0.95 2.71E-14 1.12E-12 PA1384 UDP-glucose 4-epimerase
AZPAE14712_2411_01394 206G 0.928 2.19E-16 1.38E-09 PA2353 Conserved hypothetical protein
AZPAE14712_2411_01394 198P 0.0739 1.01E-15 4.72E-09 PA2353 Conserved hypothetical protein
AZPAE14712_2411_01394 200R 0.0739 1.01E-15 4.72E-09 PA2353 Conserved hypothetical protein
AZPAE15072_2259_00589 283T 0.0503 2.71E-14 1.70E-08 PA3848 Hypothetical protein
AZPAE15072_2259_00888 176D 0.0503 2.71E-14 1.70E-08 PA3594 Probable transcriptional regulator
AZPAE15072_2259_02084 305K 0.0503 2.71E-14 1.70E-08 PA0242 Hypothetical protein
https://doi.org/10.1371/journal.ppat.1009681.t003
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PA5438ΔSLR, to determine whether these three amino acids affect the transcriptional regula-
tor function or not.
PA5438 is a transcriptional repressor that directly binds to the promoter region of the
aceA (isocitrate lyase) gene and has been shown to repress the expression of the glcB (malate
synthase) gene during growth in a non-C2 carbon source [42]. These repressed genes encoding
enzymes involved in the glyoxylate shunt (GS) pathway (Fig 3E). To determine whether the
suppressive activity of PA5438 is lost in the PA5438ΔSLR mutant, gene expression levels of
aceA and glcB were measured by quantitative real-time PCR (qRT-PCR). The qRT-PCR results
show that the expression level increased 17-fold for aceA and 5-fold for glcB (Fig 3F). Based on
Fig 3. SLR deletion in PA5438 increases the expression level of aceA and glcB. (A) Total amino acid residues of PA5438 are presented and each amino acid
locus is represented by individual squares. The color of each square indicates the lrt p-value assigned to that amino acid residue based on Pyseer results and
colors are assigned according to the index above the heatmap, which was based on the negative logs of the maximum and minimum lrt p-values from the
Pyseer result of amino acid locus. ‘N’ and ‘C’ mark the N- and C-terminus of PA5438, respectively. Residues at locus 272–274 of PA5438 with significant lrt p-
values are underlined in red. (B) Comparison of the reference PA5438 to a homolog protein from a CF-isolated genome (18A_661_02419) is shown. The red
arrow indicates deletion of SLR residues in PA5438 and corresponds to the red-underlined locus observed in A. (C) Phylogenetic tree of 636 genomes and
their associated disease status are shown. Red and black lines in the ‘id’ row indicate genomes isolated from CF and non-CF patients, respectively. Red lines in
the second, third, and fourth rows (272nd, 273rd, and 274th) each correspond to the absence of S, L, R residues, respectively. One exception to this is the red line
in row 274 (asterisk-arrow), which was detected as R substituted by C. (D) A domain search result of PA5438 by SUPERFAMILY 2 is shown and the position
of the SLR sequence inside the SIS domain is highlighted in bold. (E) AceA (isocitrate lyase) and GlcB (malate synthase) are enzymes involved in the glyoxylate
shunt pathway (highlighted in red). (F) RNAs of PAO1, the PA5438ΔSLR mutant, and the complementation strain were extracted at OD600nm ~1.0 in LB
medium and relative expression levels of aceA and glcB were measured. ��p<0.01.
https://doi.org/10.1371/journal.ppat.1009681.g003
PLOS PATHOGENS Genome-wide association study of pseudomonas aeruginosa cystic fibrosis isolates
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009681 June 23, 2021 8 / 27
these findings, we expect that the deleted SLR sequence in PA5438 is an important region for
determining aceA and glcB expression levels.
Further investigation of the PA5438ΔSLR mutant was performed to identify phenotypes
that may aid in the adaptation of the strain to the CF environment. First, we assessed the phe-
notype of the mutant PA5438ΔSLR in LB media as growth rates of diverse CF isolates in LB
media closely approximate those of CF isolates grown in artificial sputum medium (ASM)
and synthetic CF sputum medium (SCFM) [17]. Slower growth in LB was observed in the
PA5438ΔSLR mutant compared to PAO1 and the complementation strain, especially during
the exponential phase (Fig 4A). In a recent study, RccR of Pseudomonas fluorescens, a PA5438
homolog, was shown to control pyruvate metabolism as well as the GS pathway [43]. Interest-
ingly, pyruvate dehydrogenase (aceE) and aceA were regulated differently in the presence of
Fig 4. SLR deletion in PA5438 affects antibiotic susceptibility in LB medium. (A) Growth curves of PAO1, PA5438ΔSLR mutant, and the
complementation strain in LB were observed over 12 hours. ��p<0.01; ���p<0.001 (B) RNAs of PAO1, PA5438ΔSLR mutant, and the complementation strain
were extracted at OD600nm ~1.0 in LB and relative expression levels of aceE were measured. ��p<0.01; ���p<0.001 (C) AceE (pyruvate dehydrogenase) is an
enzyme involved in the entrance of The Krebs Cycle (highlighted in red). (D) Growth curves of PAO1, PA5438ΔSLR mutant, and the complementation strain
in LB supplemented with 10mM sodium acetate were observed over 12 hours. (E) Antibiotic susceptibility tests against ciprofloxacin (Cip) and 10 mM
sodium acetate (SA) were performed. Initial OD600nm of PAO1, mutant, and the complementation strain were adjusted to 0.005, and OD600nm was measured
after 20 hours of static incubation in LB supplemented with Cip. The concentration of antibiotic was 0.125 μg/ml. ���p<0.001.
https://doi.org/10.1371/journal.ppat.1009681.g004
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2-keto-3-deoxy-6-phosphogluconate (KDPG), which is bound to RccR [43]. We measured the
relative expression level of aceE at the exponential phase because pyruvate metabolism affects
growth. The expression of aceE in the mutant was suppressed compared to wildtype PAO1
and the complementation strain (Fig 4B). AceE generates acetyl-CoA from pyruvate, which
feeds into the TCA cycle (Fig 4C). Therefore, we considered if the addition of metabolites
related to this enzyme reaction (either as a precursor or product) would achieve recovery of
growth. A defect in mutant growth was still observed with the addition of sodium pyruvate
and sodium citrate, but the addition of sodium acetate as a substitute of acetyl-CoA resulted in
a complete recovery of growth (Fig 4D).
Since antibiotic tolerance can be associated with slow-growing or non-dividing “persister”
bacteria [44], we measured susceptibilities of PAO1, PA5438ΔSLR and the complementation
strain to different classes of antibiotics (tobramycin and ciprofloxacin) commonly used to
treat PA infection in CF patients. In static cultures with tobramycin or ciprofloxacin, the
PA5438ΔSLR mutant reached a significantly higher OD600nm in ciprofloxacin compared to
wildtype PAO1 and the complementation strain, but only slightly higher OD600nm in tobramy-
cin (Figs 4E and S2A). Since growth in LB recovered with sodium acetate (Fig 4D), we per-
formed antibiotic susceptibility tests with sodium acetate supplementation. A limited increase
of tobramycin susceptibility was observed in PA5438ΔSLR (S2A Fig), whereas susceptibility to
ciprofloxacin was fully restored to that of the wildtype PAO1 and complementation strain (Fig
4E). Therefore, we postulate that slower growth is involved in the decreased susceptibility of
the PA5438ΔSLR mutant to the two antibiotics.
Evidently, the composition of nutrients in LB media is very different to that of the CF spu-
tum. Therefore, a synthetic medium was prepared to mimic the nutritional makeup of CF spu-
tum (SCFM) and used it to measure growth. Unlike growth in the LB medium, in SCFM,
wildtype PAO1, PA5438ΔSLR and the complementation strain showed similar growth (S2B
Fig). Since the decreased expression level of aceE seemed to be an important factor of growth
in LB medium, we measured the expression levels of aceE in PA cultured in SCFM. The
expression level of aceE in the PA5438ΔSLR mutant was similar to that of the wildtype PAO1
and complementation strain (S2C Fig). In contrast, aceA and glcB expression levels were sig-
nificantly increased in the PA5438ΔSLR mutant compared to the wildtype and complementa-
tion strain grown in SCFM (S2D Fig).
PA produces pyocyanin, an important virulence factor derived from phenazine and forms
blue-green pigments. Pyocyanin induces reactive oxygen species (ROS) generation by transfer-
ring electrons to oxygen and increasing neutrophil apoptosis as a way of disrupting the host
immune system [45]. As such, the supernatant color of a PA culture can function as a proxy
for the virulent nature of the bacterium. Interestingly, we observed the 8 hour culture superna-
tant of PA5438ΔSLR in SCFM to be greener than that of the PAO1 and the complementation
strain (Fig 5A). When we confirmed the relative pyocyanin levels of this bacterial culture, the
PA5438ΔSLR mutant in SCFM resulted in 6~7 times more pyocyanin than PAO1 and the
complementation strain (Fig 5A). Pyocyanin stimulates iron removal from transferrin in bac-
teria incubated under low oxygen conditions [46], and the level of transferrin is increased in
the bronchoalveolar fluid from CF patients, compared to that of healthy individuals [47].
Therefore, we measured biofilms in which oxygen is limited, using the iron-saturated holo-
transferrin. Compared to PAO1 and the complementation strain, the PA5438ΔSLR mutant
produced less biofilm in SCFM, as demonstrated by a decreased OD550nm absorbance value.
However, in the presence of transferrin, the mutant produced a similar level of biofilm whereas
the PAO1 and the complementation strain produced less biofilms than in SCFM (Fig 5B).
Potential implications in CF airway infections. These findings have potential implica-
tions in CF airway infections. An altered fatty acid profile has been associated with the airways
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of CF patients. For example, higher concentrations of palmitic acid and oleic acid have been
detected in CF airway samples [48]. Fatty acid degradation upregulates the glyoxylate shunt
(GS) pathway [49], and PA isolated from the CF lungs can induce the expression of genes
involved in fatty acid metabolism and the GS pathway [50]. Furthermore, mucin is a major
energy source in the CF lung environment in addition to fatty acids, and the GS pathway is
important for mucin degradation and consumption [51]. Meta-transcriptomic analysis of sev-
eral CF sputum samples in another study also found that aceA was upregulated and genes asso-
ciated with glucose transporters and glycolysis were significantly downregulated [52]. Based
on these previous studies, we assumed that the activation of the GS pathway may provide an
advantage for PA proliferation in CF lungs.
Previous observations of GS pathway upregulation [50,52] are probably due to the presence
of CF isolates that contain the abnormal PA5438 gene. In the PA5438ΔSLR mutant, aceA and
glcB expression levels were increased not only in LB but also in SCFM. To investigate if the
end products of the upregulated expression of aceA and glcB are functional, we examined the
sequences of AceA and GlcB from genomes that harbor ΔSLR. Both promoters and proteins of
AceA and GlcB were highly conserved (Table A, Table B in S1 Table). This indicates that the
SLR deletion is the sole contributor to the transcriptional regulation of these two genes.
Glyoxylate shunt pathway is necessary for surviving phagocytosis and is upregulated in
response to ROS [53,54]. We performed a gentamicin protection assay using our strains and
mouse bone-marrow-derived neutrophils to measure how well the PA5438 mutant endures
ROS-enriched and nutrient-poor phagocytic environment. We did not observe a significant
Fig 5. SLR deletion in PA5438 affects virulence and biofilm production in SCFM. (A) After bacterial culture of PAO1, PA5438ΔSLR mutant, and the
complementation strain in SCFM for 8 hours with shaking, a pyocyanin assay was performed with culture supernatant, and relative pyocyanin level was
calculated using PAO1 pyocyanin level. Bacterial cultures used in pyocyanin assay are shown. ��p<0.01 (B) After 32 hours of static culture of PAO1,
PA5438ΔSLR mutant and the complementation strain in SCFM and SCFM supplemented with holo-transferrin (TF), biofilm was measured
spectrophotometrically. ��p<0.01; ���p<0.001.
https://doi.org/10.1371/journal.ppat.1009681.g005
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difference in the CFUs of the PA5438 mutant strain compared to the wild type and the com-
plementation strains in our experiment (S2E Fig).
As CF isolates have similar growth rates in LB and SCFM [17], we chose LB as the medium
in which to investigate phenotypic differences between the wildtype and mutant PA. However,
we observed a marked difference between the growth of the PA5438ΔSLR mutant cultured in
LB and SCFM. In addition, the bacterial culture head a greener colour when SCFM was used
(Fig 5A) than when LB was used. Given that PA5438 is involved in energy metabolism [43],
we hypothesized that the mutant and wildtype phenotypes may vary depending on the type
of medium used (LB or SCFM). Therefore, virulence phenotypes of the mutant, such as the
increased pyocyanin levels observed in SCFM, are more likely to occur in the CF environment
than the decreased antibiotic susceptibility observed in LB cultures. We also examined the
genes involved in pyocyanin biosynthesis in the genomes that carry the PA5438ΔSLR muta-
tion. Whereas several genomes were found to carry mutations in several of these genes when
compared with the PAO1 sequences, other genomes possess a highly conserved gene set
(S3 Fig). Based on this finding, we anticipate that virulent phenotypes such as that of the
PA5438ΔSLR mutant are likely to manifest in the CF lung environment.
Despite differences in the nutrient compositions of LB and SCFM, the mutant phenotypes
observed in LB cultures provide evidence that PA5438 acts as a transcriptional regulator. RccR
of Pseudomonas fluorescens, a PA5438 homolog, has been shown to possess an SIS domain, the
binding affinity of which is regulated by 2-keto-3-deoxy-6-phosphogluconate (KDPG) [43].
This KDPG-dependent moderation of PA5438 binding affinity is also dependent on the gene
with which PA5438 binds. In the absence of KDPG, the binding affinity of PA5438 to aceE is
increased, whereas its binding affinity to aceA is decreased [43]. A domain search using the
SUPERFAMILY 2 database detected the SLR amino acid sequence of PA5438 to be inside the
SIS domain (Fig 3D). The qRT-PCR results showed a decreased aceE gene expression level and
an increased aceA gene expression level in LB (Figs 3F and 4B). Based on these findings, we
propose that the SLR amino acid sequence may be a key region to which KDPG binds. In con-
trast to LB culture, in SCFM culture the aceE gene expression by the PA5438ΔSLR mutant is
similar to that of wildtype PAO1 and the complementation strain. This observation may be
attributed to the preferential use of amino acids over glucose in SCFM, which may lead to a
decreased intracellular level of KDPG in the exponential phase of PA cultured in SCFM, unlike
in LB. Further investigations are needed to conclusively determine whether KDPG indeed
binds to the SLR region of PA5438.
Furthermore, elastase and pyocyanin are well-characterized virulence factors regulated by
quorum sensing. We performed an elastase assay to test whether quorum sensing is related to
the increased pyocyanin level [20]. Similar to the pyocyanin assay results, which showed a sig-
nificant increase in pyocyanin in the PA5438ΔSLR mutant, relative elastase activity was slightly
increased in the mutant compared to wildtype PAO1 and the complementation strain (S2F
Fig). Therefore, we anticipate the increased pyocyanin level to be mediated by the quorum-
sensing system. Pyocyanin stimulates iron removal from transferrin when PA is grown in low
oxygen conditions [46], and increased levels of transferrin have been observed in CF patients
[47]. Biofilm is a matrix of extracellular polymeric substances which protects the bacterial cells
beneath, and oxygen supply is limited in developed biofilms [55]. Biofilm production of the
PA5438ΔSLR mutant is decreased compared to PAO1 and the complementation strain in
SCFM. In SCFM with transferrin, the mutant maintains the level of biofilm production,
whereas PAO1 and the complementation strain produced less biofilms (Fig 5B). This implies
that the mutant maintenance of biofilm production level in the presence of transferrin may
confer greater fitness in the transferrin-enriched CF environment. Based on our experimental
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results, we speculate that this mutant may be problematic in the CF lung due to its increased
virulence and biofilms.
Mutations in the L-cystine transporter (YecS, PA0313)
Identification and experimental validation. A major limitation of aligning 31-mers to
the PAO1 reference genome is that the 31mers that do not align due to insertion mutations
are overlooked. To determine the reference genes for such insertion mutations, un-aligned
31-mers were de novo assembled, and the contigs that formed were mapped to 635 genomes
(excluding PAO1). The top 10 amino acid residues with corresponding 31-mers that do not
align to the PAO1 genome are described in Table 3. Three amino acid residues at loci 162–164
(Fig 6) had significant lrt p-values compared to other amino acid residues. At these loci, the
YecS homolog had insertions of three amino acid residues, SLI (Fig 6). Moreover, there was
an additional copy of SLI in the AU17965_3981_04951 protein, comprising a total of three
stretches of ‘SLI’, in contrast to a total of two stretches in the PAO1 YecS (S4 Fig). SLI inser-
tions were strongly associated with CF isolates (Fig 6C) and the YecS homologs of these iso-
lates were identical to the reference AU17965_3981 sequence, except for the additional SLI in
PAO1 YecS. The AU17965_3981_04951 protein is a cytoplasmic-membrane transporter, and
the additional ‘SLI’ sequence is thought to span both cytoplasmic and transmembrane regions
(S5A and S5B Figs) [56].
To experimentally assess if the SLI insertion effects a phenotypic change, an in-frame
mutant was constructed with the additional SLI sequence inserted into the corresponding
locus of PAO1 YecS. No difference in growth was observed between the wildtype PAO1 and
the YecSOSLI mutant when both strains were grown in SCFM (S5C Fig). However, in M9
minimal media supplemented with glucose and L-cystine as the sole sulfur source, the mutant
grew slower than PAO1 and the complementation strain, whereas growth in M9 media with
an additional sulfur source present (MgSO4) showed no difference (Figs 6D and S5D).
Two L-cystine transporters are known in E. coli, an ATP-binding cassette (ABC) importer
(FliY-YecSC) and symporter YdjN [57]. Previous work has shown that the presence of either
of the two transporters is sufficient to meet the L-cystine requirement for normal growth when
L-cystine is used as the sole sulfur source [57]. We performed a blastp search of 636 genomes
using the database of 238 YdjN homologs [58] and concluded that 635 out of 636 genomes
do not seem to encode a YdjN homolog (S5 Data). Therefore, based on our blast search and
experimental result (Fig 6D), we hypothesize that PAO1 only possesses the ABC importer sys-
tem for L-cystine uptake. Moreover, the decreased growth of the SLI insertion mutant is attrib-
uted to the decreased activity of the ABC transporter rather than a complete loss of function. A
comparison of growth between a YecS clean deletion mutant and our SLI insertion mutant
would help in better understanding the assortment of L-cystine transporters present in PA.
Potential implications in CF airway infections
In addition to the SLI insertion mutation, we focused on other patterns of mutation in YecS
that were observed across the CF isolate genomes. One such pattern is the deletion of an SLI
sequence that results in CF isolates encoding just one SLI sequence in YecS homologs (S4A
Fig). Another pattern of mutation observed by multiple alignments of YecS homologs is the
deletion of long stretches of amino acid residues (S4B Fig). Since the SLI insertion mutant
exhibited decreased L-cystine transporter activity (Fig 6D), we anticipate that such large dele-
tions in the YecS protein would incur a complete loss of function.
Amino acid concentrations in the sputum vary across individual CF patients [59] and cyste-
ine levels can be low or even undetectable [59]. Since cysteine is oxidized to cystine, a low level
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of one may indicate a low level of the other in the CF lung. Therefore, on one hand, large dele-
tions in YecS may provide a survival advantage by allowing the CF isolate to avoid the energy
cost of maintaining a functional YecS transporter in the cysteine-deficient CF lung environ-
ment. On the other hand, the reduction of intracellular cystine to cysteine contributes to ROS
production in E. coli [60]. Thus, we expect small-scale mutations in YecS may be a result of
evolution that protects the CF isolates from ROS stress in the cysteine-present CF lung envi-
ronment. Additionally, pyochelin is a well-known siderophore produced by PA. Pyochelin
Fig 6. SLI insertion in YecS reduces L-cystine utilization activity. (A) The amino acid residues of CF-derived AU17965_3981_04951 protein are presented and
each amino acid locus is represented by individual squares. The color of each square indicates the lrt p-value assigned to that amino acid residue based on Pyseer
results and colors were assigned according to the index above the heatmap. The color index was generated based on the negative logs of the maximum and
minimum lrt p-values from the Pyseer result of the amino acid locus. ‘N’ and ‘C’ mark the N- and C-terminus of AU17965_3981_04951, respectively. Residues
presenting especially low lrt p-values are marked with a red underline and were found at loci 162–164 of the AU17965_3981_04951. (B) Comparison of the
reference AU17965_3981_04951 to its PAO1 homolog YecS (PA0313) is shown. The red arrow indicates insertion of SLI residues in AU17965_3981_04951 and
corresponds to the red-underlined locus observed in (A). (C) Phylogenetic tree of 636 genomes and their associated disease status are shown. Red and black lines
in the ‘id’ row indicate genomes isolated from CF and non-CF patients, respectively. Red lines in the second, third, and fourth rows indicate the presence of SLI
insertion in PAO1 YecS. (D) Growth curves of PAO1, YecSΩSLI mutant and the complementation strain cultured in M9 minimal media with MgCl2 instead of
MgSO4, supplemented with glucose and L-cystine as the sole sulfur source were measured over 30 hours.
��p<0.01; ���p<0.001 (E) After bacterial culture of
PAO1, YecSΩSLI mutant, the complementation strain and the ΔpchΔpvd mutant, a pyochelin- and pyoverdine- deficient strain, in SCFM for 6 hours with
shaking, the pyochelin in the bacterial culture supernatant was measured. �p<0.05; ��p<0.01.
https://doi.org/10.1371/journal.ppat.1009681.g006
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may inflict tissue damage in the CF lung by inducing a continuous inflammatory response
[61]. Interestingly, cysteine is a precursor molecule required for the production of pyochelin
[62]. Therefore, we tested the effect of SLI insertion in YecS on pyochelin production of
PAO1, the YecSOSLI mutant, the complementation strain, and a ΔpchΔpvd mutant [63] that
does not produce pyochelin and pyoverdine. The SLI insertion mutant exhibited decreased
pyochelin production compared to the wildtype and the complementation strain (Fig 6E). A
decreased level of pyochelin may be associated with a less virulent phenotype of the mutant,
which may be an adaptation strategy for establishing a chronic infection in the CF lung envi-
ronment. Whereas several genomes carried mutations in pyochelin biosynthesis genes, when
compared with the PAO1 sequences, other genomes possess a highly conserved gene set (S6
Fig). Therefore, it may be the case that less virulent phenotypes such as that of the YecSOSLI
mutant proliferate in the CF lung environment.
Small-scale alterations in intergenic regions: phuS and phuR
Comparison of genomes using k-mers enables the investigation of intergenic regions. Of all
contigs assembled from significantly different 31-mers, between CF and non-CF isolates, 29
contigs aligned to the non-coding regions of the PAO1 genome. Most aligned to either the hs
region or rDNA sequences (Fig 1B). Since mutations located in the hs region may cause gene
deletions, and rDNA sequence regions were excluded from analysis due to difficulties in inter-
pretation, we selected regions other than these loci. Among several such intergenic regions,
one intergenic region between phuR and phuS operons, was involved in the pseudomonas
heme utilization (phu) systems (Fig 7A). The function of such a system is the acquisition of
iron from the heme group of hemoglobin [64]. To evaluate the potential role of these muta-
tions in CF adaptation, Pyseer analysis was performed using the nucleotide sequences of this
intergenic region from PAO1 and other isolates (Fig 7B). The most significant hit was the tran-
sition of the 117th residue on the forward strand from cytosine (C) to thymine (T) (Fig 7B).
Two mutations (C117T and C122T) are included in the phuR promoter region (from -35
region to transcriptional initiation site (+1)) (Fig 7C).
Consistent with our findings, the frequency of mutations within this intergenic region in a
CF isolate were found to increase significantly compared to the background mutation rate,
and the mutated intergenic region increased phuR promoter activity [65]. In some cases, the
intergenic region was deleted (Fig 7D) and the promoter activity is probably absent in these
isolates. When such cases of promoter deletion are excluded from the analysis, a stronger cor-
relation is expected between the mutations of this region and CF isolates. To examine whether
the C117T point mutation affects the expression of phuR, we performed a promoter activity
assay by measuring β-galactosidase activity. Promoters with this mutation exhibited increased
activity (Fig 7E). Therefore, increased phuR promoter activity will ultimately result in
increased phu system activity. We speculate that the C117T mutation is an important strategy
for iron uptake and thus survival in the CF environment.
Conclusions
In this study, we compared a large set of genomes from clinical PA isolates (CF vs. non-CF)
and identified mutations that occurred differentially in either CF or non-CF isolates using
GWAS based on 31-mer counting (Fig 8). To integrate these findings within a functional geno-
mics context [66], the impact on bacterial growth- and virulence-associated phenotypes was
also assessed. Importantly, PAO1-derived variants, PA5438ΔSLR and YecSOSLI, exhibited dis-
tinct phenotypes in in vitro assays. Moreover, a single nucleotide replacement in the promoter
region of the phuR gene caused a considerable increase in gene transcription. Together, these
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results suggest that PA may benefit from small-scale mutations when establishing chronic
infections in the CF airway. Mutations in the lasR gene encoding a QS regulator have been
reported as frequent in CF isolates [7,8]. However, we found no evidence that mutations in
LasR or other QS-related proteins were significantly overrepresented in CF or non-CF isolates.
Given that the MucA mutation was represented in our analysis, demonstrating the precision
of our bioinformatic approach, the lasR mutation might in fact be a common feature in PA,
either causing chronic CF infection or other acute infections. Finally, while our study improves
understanding the genetic changes in PA associated with chronic CF airway infection, they do
not reveal the order in which these genetic changes occurred. Evaluating the chronology of
adaptative changes in the CF lung will be important for explaining the persistence of PA.
Fig 7. One SNP in the phuR promoter region increases expression level. (A) The 180 bp intergenic region between phuR and phuS is shown. (B) The
top 5 associated SNPs detected using Pyseer within this intergenic region are listed and the number in the ‘residue of mutation’ column indicates the
forward strand-based locus of mutation. The nucleotide in front of the locus number indicates the reference base in the intergenic region, whereas the
nucleotide following the locus number indicates the changed base. Information contained in the following three columns is similar to those described
in Fig 2B. (C) Promoter region of phuR (region from -35 to +1) based on the PRODORIC database [84] is visualized with WebLogo [85], and SNPs
listed in (B) are marked by asterisks. The height of a stack reflects the degree of sequence conservation at that position, while the height of symbols
within a stack indicates the relative frequency of each nucleotide at that position. The upper sequence is derived from the intergenic regions of CF
genomes and the sequence below is based on intergenic regions of non-CF genomes. (D) Red and black lines in the ‘id’ row indicate genomes of CF and
non-CF isolates, respectively. Red lines in the bottom five rows indicate mutations at each locus, shown in (B), and yellow lines indicate that this
intergenic region is missing from the genome. (E) Culture of phuR::lacZ and phuRC117T::lacZ grown to OD600nm ~0.25 were used in a β-galactosidase
assay, to compare phuR promoter activity. ���p<0.001.
https://doi.org/10.1371/journal.ppat.1009681.g007
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Experimental procedures
Bioinformatic analysis. Overall, 2,187 PA genomes were downloaded from the Pseudo-
monas Genome Database [27], and 1,001 genomes with information on the host disease were
selected. A phylogenetic tree was created with RapidNJ, using Snippy-generated alignments of
the core genome as input [67,68], and visualized with Microreact [69]. Based on the initial
tree, the selection of genomes was trimmed down with Treemmer [70] to include 636 isolates
while maintaining 99.8% of the original diversity (S1 Data). The prediction of protein-coding
genes in the 636 genomes was performed using Prokka [31]. K-mers of 31 base pairs length
(31-mers) were counted in the 636 individual genomes with Fsm-lite [71]. A similarity matrix
was constructed with Snp-sim [72] using a core alignment of 636 genomes generated by
Snippy [68]. Pyseer [29], which uses a mixed model (FaST-LMM), was run using the counted
k-mers and the similarity matrix as input, and lrt p-values were assigned to each 31-mer. To
determine the 31-mers that were significantly different between CF and non-CF groups,
31-mers with poor chi values (indicative of invalid χ2 test) or lrt p-values above 2.8e-08 (cutoff
value in this analysis) were removed. As a result, 41,685 31-mers were detected to have signifi-
cant associations with either disease status (CF or non-CF). Distribution of these 31-mers
aligned to the PAO1 whole genome was visualized with Phandango [30]. Subsequently, de
Fig 8. Schematic diagram with candidate genes. Gene products of both (1–4) large- and (5–7) small-scale mutations significantly found in CF are
illustrated with BioRender.com. We anticipate several phenotypic changes to arise as result of these mutations: (1) Large-scale mutations in the MucA
protein stimulate alginate production which is an important component of biofilm; (2) PA2321 and PA3193 are involved in glucose catabolism.
Disruption of PA2321 and PA3193 may be results of evolution in the CF environment which is enriched in free amino acids, nutrients preferred by P.
aeruginosa; (3) Large-scale mutations in the PA2020 regulator upregulates expression level of MexXY, which may in turn result in increased antibiotic
resistance; (4) Mutations in mannitol utilization gene cassette may aid in defence against the combined treatment of aminoglycoside and mannitol; (5)
SLR deletion in PA5438 induces the glyoxylate shunt pathway, pyocyanin production and maintenance of biofilm in the presence of transferrin; (6) SLI
insertion in YecS decreases cystine uptake and pyochelin production; (7) Mutation in phuR promoter region increases phuR expression.
https://doi.org/10.1371/journal.ppat.1009681.g008
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novo assembly of these 31-mers was completed using Trinity [73]. Overall, 489 contigs were
constructed, and these contigs mapped to 29 intergenic regions, six untranslated regions, and
109 translated genes of the PAO1 genome with Blastn. Individual contigs that aligned to either
protein-coding regions or intergenic regions were blasted against 635 genomes (the PAO1
genome was excluded) [74]. The top hit from each pairwise alignment with a blast e-value
<0.01 was chosen as a homolog of the candidate sequence in each isolate.
In 453 contigs mapping to protein-coding regions, homologs were clustered under several
conditions of similarity and gene length coverage (S95L95 -: 95% similarity and 95% length
coverage; S70L95–70% similarity and 95% length coverage) using Blastclust [74]. Homologs
that clustered with the reference PAO1 protein were assigned as ‘1’ and those that did not were
assigned ‘0’. We then used the clustering matrix as input for Pyseer. Clusters with either poor
chi values or lrt p-values larger than 3.22E-05 were removed. In this manner, genes with multi-
ple co-localized mutations were determined and defined as ‘large-scale’ mutations (Fig 1C).
Other protein-coding region mutations were treated as ‘small-scale’ mutations.
Where contigs mapped to protein-coding regions or intergenic regions, multiple alignment
of the candidate sequence and its homologs was performed using Mafft [75]. This allowed
characterization of nucleotides (for intergenic region candidates) or amino acid sequences
(for protein-coding genes) at each locus for detecting small-scale mutations. If the residue of
a homolog was identical to that of the reference PAO1 intergenic region or protein, it was
assigned a value of ‘1’ at that locus, and if not, a value of ‘0’ was assigned. In this way, a locus
matrix was created for use as the input for Pyseer and loci with either poor chi values or lrt p-
values larger than 4.01E-06 were removed.
Finally, k-mers that failed to align to the PAO1 genome were also analyzed. However,
the PAO1 reference gene in these cases was replaced with the reference gene detected in alter-
native isolate genomes. As such, we were able to investigate the presence of insertion muta-
tions. For KEGG functional annotation and pathway analysis, BlastKoala [34] was used
with large-scale mutations. Sequence comparison was performed by Clustalw [76] and multi-
ple alignment was visualized with Jalview [77]. SUPERFAMILY 2 [41] search was used to
investigate the domains of the PA5438 gene. Transmembrane domain prediction of the
AU17965_3981_04951 protein was carried out using Phobius [56].
Bacterial strains and growth conditions. All bacterial strains and plasmids used in this
study are shown in Table C in S1 Table. PAO1 was used as a reference strain [1]. Bacterial cul-
tures were grown in LB medium (1% [w/v] tryptone, 0.5% [w/v] yeast extract, and 1% [w/v]
sodium chloride) at 37˚C and Synthetic Cystic Fibrosis Medium (SCFM) using a previously
described protocol [59]. Single bacterial colonies were picked from LB plates and inoculated
in fresh LB or SCFM broths for precultures and grown overnight. Precultures were diluted
100-fold in fresh LB broth to subculture and incubated at 37˚C with shaking at 230 rpm. For
SCFM cultures, bacterial preculture was diluted and inoculated to the starting OD600nm 0.025
in fresh SCFM broth for subculture. All SCFM cultures were incubated under the same condi-
tions as LB cultures, except for the incubation time, which was dependent on specific experi-
mental procedures.
In-frame mutant construction
All in-frame mutants, including an SLI insertion in the YecS protein and SLR deletion in the
PA5438 protein, were constructed from the PAO1 strain. In-frame insertions and deletions
were performed to construct mutants with amino acid level changes. In the case of the in-frame
deletions, the 50 and 30 flanking regions were designed to overlap in both directions of SLR. For
the in-frame insertion, nucleotide sequences corresponding to amino acid sequence ‘SLI’ were
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inserted into the middle of the 50 flanking region. An overlap was constructed by using each 50
primer of 50 flanking region and 30 primer of 30 flanking region. For both deletion and insertion
mutations, an overlapping product was inserted into modified pCVD442, a suicide vector, con-
taining gentamicin and ampicillin resistance markers. PAO1, grown on LB agar, was conjugated
with E. coli SM10 λpir, harboring pCVD442 with the overlapping product inserted, grown on
LB agar with 50 μg/ml ampicillin and 30 μg/ml gentamicin. Conjugates were spread onto LB
agar with 50 μg/ml gentamicin and 20 μg/ml irgasan to select single crossover recombinants.
The single crossover recombinant was incubated on LB agar without NaCl but containing 8%
sucrose for the selection of the desired mutant. Sequence verification was performed by PCR.
Primers used in constructing these mutants are listed in Table D in S1 Table.
Complementation
Identical primers were used in constructing the aforementioned mutants (Table D in S1 Table;
PA5438#1, PA5438#4, yecS#1, and yecS#6), and were used to amplify the yecS and PA5438
sequences of wildtype PAO1. The amplified wildtype sequences were each inserted into
pCVD442, and identical steps of mutant construction were followed to generate the comple-
mentation strains of the YecSOSLI and PA5438ΔSLR mutants.
Promoter assay
To perform the phuR gene promoter assay, intergenic regions (180 bp) between phuS and
phuR in the PAO1 genome and AU2342_3932 [78] with only the 117th locus changed from
cytosine to thymine were amplified with primers listed in Table D in S1 Table. These PCR-
products were each cloned into the upstream region of the β-galactosidase gene of puc18-
mini-Tn7t-Gm-LacZ [79] for chromosomal insertion. The constructed plasmid was trans-
formed into E. coli DH5α λpir. After verification by DNA sequencing, the plasmids with the
helper plasmid pTNS2 that encodes TnsABC+D genes (allowing Tn7 transposition) were elec-
troporated into PAO1. Empty puc18-mini-Tn7t-Gm-LacZ plasmid with no insert was used as
a control to measure the baseline expression of lacZ. The potential clones were selected on LB
agar with 50 μg/ml gentamicin and sequence verification was performed to select the final can-
didates whose transposon was inserted properly into the region following the glmS gene. β
-galactosidase activities of the three clones (con::lacZ, phuR::lacZ, and phuRC117T::lacZ),
summarized in Table C in S1 Table, were grown in LB and measured at the exponential phase
(OD600nm ~0.25).
Growth curves
Wildtype PAO1, the PA5438ΔSLR mutant, and the complementation strain were precultured
overnight in LB broth. Precultures were diluted 100-fold in fresh LB and incubated at 37˚C
with shaking at 230 rpm. Growth in LB was observed over 12 hours and the OD600nm was mea-
sured. Growth in SCFM was detected in the same manner over a period of 8 hours. Growth
recovery tests of the PA5438ΔSLR mutant were performed using LB medium and LB supple-
mented with 10 mM sodium acetate (Sigma-Aldrich, USA), 10 mM sodium pyruvate (Sigma-
Aldrich, USA), and 10 mM sodium citrate (Sigma-Aldrich, USA), and OD600nm were mea-
sured at regular time intervals. To examine the functional capacity of the L-cystine transporter,
overnight precultures of PAO1, the YecSOSLI mutant, and the complementation strain were
washed in phosphate-buffered saline (PBS), and diluted to OD600nm ~ 0.025 in fresh M9 mini-
mal media supplemented with 22.2 mM glucose and L-cystine (0.25 mM) as the sole sulfur
source (2 mM MgCl2 instead of MgSO4). OD600nm was measured over 30 hours. Growth was
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also measured over 21 hours under identical conditions, except for the inclusion of 2 mM
MgSO4 (instead of MgCl2) in M9 minimal media.
Antibiotic susceptibility test
For antibiotic susceptibility tests, ciprofloxacin (Duchefa, The Netherlands) and tobramycin
(Sigma-Aldrich, USA) were used. Wildtype PAO1, the PA5438ΔSLR mutant, and the comple-
mentation strain were precultured overnight in LB broth. Bacterial preculture was diluted in
LB containing the relevant antibiotics (ciprofloxacin or tobramycin) and the starting OD600nm
was adjusted to 0.005. For static cultures, the antibiotic concentrations used were 0.125 μg/ml
ciprofloxacin and 1 μg/ml tobramycin. OD600nm was measured after 20 and 26 hours of static
incubation with ciprofloxacin and tobramycin, respectively. An antibiotic susceptibility test
with 10 mM sodium acetate supplementation was conducted under the same conditions.
Reverse transcription and quantitative real-time PCR
PAO1, the PA5438ΔSLR mutant, and the complementation strain were precultured and sub-
cultured in LB. After incubating the subcultures to OD600nm ~1.0, RNeasy Mini kit (Qiagen,
Netherland) and on-column DNase1 digestion were used to extract RNA following the manu-
facturer’s protocol. 1 μg of RNA was reverse-transcribed to synthesize complementary DNA
by using reverse transcriptase (Takara Bio, Japan) and random hexamer primers. To check for
DNA contamination, the same cDNA synthesis was performed in the absence of reverse tran-
scriptase. SYBR green-based qPCR was performed using an ABI 48-well StepOne real-time
system. The primers used are listed in Table D in S1 Table. CT values were normalized by
16S rRNA CT values. SCFM cultures (OD600nm ~0.9) followed identical RNA extraction and
qRT-PCR procedures.
Elastase and pyocyanin tests
Precultures of PAO1, the PA5438ΔSLR mutant, and the complementation strain were pre-
pared for elastase and pyocyanin tests in SCFM as described above. Bacterial supernatant was
harvested from bacterial subcultures incubated for 8 hours in SCFM, and assays were per-
formed as described previously [80,81]. Elastase and pyocyanin values were normalized using
OD600nm.
Pyochelin measurement
Precultures of PAO1, the YecSOSLI mutant, and the complementation strain in SCFM were
prepared as described above. Bacterial supernatant was harvested from bacterial subcultures,
incubated for 6 hours in SCFM, and fluorescence was measured using Varioskan Flash 3001
(Thermo Scientific, USA) at excitation wavelength 355 nm and emission wavelength 440 nm
[82]. Pyochelin values were normalized using OD600nm.
Biofilm assay
Precultures of PAO1, PA5438ΔSLR mutant, and the complementation strain in SCFM were
prepared as described above. Bacterial precultures were diluted in SCFM or SCFM containing
the holo-transferrin (Sigma-Aldrich, USA) in a 96-well plate, and the starting OD600nm was
adjusted to 0.025. For static cultures, the holo-transferrin concentration used was 1.25 μM.
After 32 hours of static incubation, biofilm assay was performed as described previously [83].
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In vitro gentamicin protection assay
Neutrophils were isolated from the bone-marrows of C57BL/6 mice following the protocol of
EasySep Mouse Neutrophil Enrichment Kit (STEMCELL, Canada). Following isolation, neu-
trophils were maintained in Opti-MEM media (ThermoFisher Scientific, USA). Precultures of
PAO1, the PA5438ΔSLR mutant, and the complementation strain in SCFM were prepared in
the manner described above. Bacterial culture was harvested from bacterial subcultures incu-
bated for 4 hours in SCFM. The initial infection dosage was 107 CFU per 5 × 105 neutrophils.
After 2 hours of co-culturing P. aeruginosa and neutrophils, the culture supernatant was
removed and fresh Opti-MEM supplemented with 50 μg/ml gentamicin was added for 1 hour.
After performing wash twice in PBS, 0.5% Triton-X was added and bacteria number were
counted by using pseudomonas isolation agar (Sigma-Aldrich, USA).
Statistical analysis
Data are expressed as mean ± standard deviation. Unpaired Student’s t-test (one-tailed,
unequal variance) was performed to analyze the differences between experimental groups.
P-values smaller than 0.05 were considered statistically significant. All experiments were
repeated for reproducibility.
Supporting information
S1 Fig. Phylogenetic tree constructed with CF and non-CF genomes. Upper phylogenetic
tree was constructed with 1,001 genomes containing host disease information, and the tree
below was drawn using 636 genomes and maintaining 99.8% diversity of the upper tree. Black
and red leaves each indicate non-CF and CF isolates, and the numbers of CF and non-CF
genomes for constructing each phylogenetic tree are placed inside brackets.
(TIF)
S2 Fig. Phenotypes of the PA5438ΔSLR mutant. (A) Antibiotic susceptibility test with tobra-
mycin (Tob) and Tob with 10 mM sodium acetate (SA) were performed. Initial OD600nm of
PAO1, PA5438ΔSLR mutant, and the complementation strain were adjusted to 0.005, and
OD600nm was measured after 26 hours of static incubation in LB supplemented with Tob.
The concentration of antibiotic was 1 μg/ml. ��p<0.01 (B) Growth curves of PAO1 and
PA5438ΔSLR mutant in SCFM were observed over 8 hours. (C) RNAs of PAO1, the
PA5438ΔSLR mutant, and the complementation strain were extracted at OD600nm ~0.9 in
SCFM and relative expression levels of aceE were measured. (D) Relative expression levels of
aceA and glcB of the same RNA used in (C) were measured. ���p<0.001 (E) The initial infec-
tion dosage was 107 CFU per 5 × 105 neutrophils isolated from the bone-marrows of C57BL/6
mice. After 2 hours of co-culturing P. aeruginosa and neutrophils, we added gentamicin to the
culture medium for 1 hour to remove any extracellular bacteria. We then harvested the intra-
cellular bacteria by treating the neutrophils with 0.5% Triton-X, and measured the bacterial
CFU. (F) After bacterial culture of PAO1, PA5438ΔSLR mutant, and the complementation
strain in SCFM for 8 hours with shaking, an elastase assay was performed with culture super-
natant. ��p<0.01.
(TIF)
S3 Fig. Blastp results of genes associated with pyocyanin biosynthesis. Each row represents
a genome containing an SLR deletion in PA5438 homologs and color indicates whether it is
included in CF or non-CF. Columns contain PAO1 proteins associated with pyocyanin bio-
synthesis and similarity (S), % of identical matches between reference PAO1 protein and its
homolog, and length coverage (L), % of reference PAO1 protein sequence covered by its
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homolog. Gray box indicates there is no homolog under e-value 0.01 in the blastp search.
(TIF)
S4 Fig. Multiple alignment of YecS and its homologs. Multiple alignment of YecS and its
homologs is visually represented. Names of the genomes are shown to the left of the multiple
alignment. PAO1 and AU17965_3981 are representative genomes of non-CF and CF groups,
and genomes labeled with red or blue belong to the CF or non-CF groups, respectively. Black
arrow marks where the additional SLI insertion occurs (162nd to 164th residues) compared to
the YecS protein. Regions marked by asterisks are regions of SLI amino acid repeat sequences
in YecS. Genomes in a contain a deletion of SLI, resulting in a single copy of SLI, and genomes
in b present large deletions in YecS.
(TIF)
S5 Fig. Transmembrane domain prediction and growth curves of the YecS mutant. (A) Pre-
dicted transmembrane domains of the AU17965_3981_04951 protein are portrayed. Numbers
below the figure indicate the amino acid loci. (B) Detailed amino acid ranges of the predicted
transmembrane domains are listed. The SLI insertion in the AU17965_3981_4951 protein is
present within the region highlighted in bold. (C) Growth curves of PAO1 and YecSOSLI mutant
in SCFM were measured over 8 hours. (D) Growth curves of PAO1 and YecSOSLI in M9 mini-
mal media supplemented with glucose, L-cystine, and MgSO4 were recorded over 21 hours.
(TIF)
S6 Fig. Blastp results of genes associated with pyochelin biosynthesis. Each row represents
a genome containing an SLI insertion in YecS homologs and color indicates whether it is
included in CF or non-CF. Columns contain PAO1 proteins associated with pyochelin biosyn-
thesis and similarity (S), % of identical matches between reference PAO1 protein and its
homolog, and length coverage (L), % of reference PAO1 protein sequence covered by its
homolog. Gray box indicates there is no homolog under e-value 0.01 in the blastp search.
(TIF)
S1 Data. Information of 636 genomes.
(XLSX)
S2 Data. Pyseer results.
(XLSX)
S3 Data. Cluster and locus information of 636 genomes.
(XLSX)
S4 Data. Amino acid sequences of small insertion variants from isolates other than PAO1.
(DOCX)
S5 Data. Blastp results with 636 genomes and 238 YdjN homologs.
(XLSX)
S1 Table. Supplementary tables.
(DOCX)
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